Clinical trial
An Open-Label Study to Compare the Lipid Effects of Niacin ER and Simvastatin…
NCT00465088 · Abbott, Industry · Completed
Key facts
| NCT number | NCT00465088 |
|---|---|
| Title | An Open-Label Study to Compare the Lipid Effects of Niacin ER and Simvastatin (NS) to Atorvastatin in Subjects With Hyperlipidemia or Mixed Dyslipidemia (SUPREME) |
| Official title | SUPREME: A 12-Week, Open-Label, Multicenter Study to Compare the Lipid Effects of Niacin ER and Simvastatin (NS) to Atorvastatin in Subjects With Hyperlipidemia or Mixed Dyslipidemia |
| Acronym | SUPREME |
| Lead sponsor | Abbott, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hyperlipidemia, Mixed Dyslipidemia |
| Intervention type | Drug |
| Interventions | Niacin ER/Simvastatin Tablets, atorvastatin |
| Enrollment | 199 |
| Start date | Apr 1, 2007 |
| Primary completion | Feb 1, 2008 |
| First posted | Apr 24, 2007 |
| Last update posted | Jun 13, 2011 |
| Countries | United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: